Roche ends a bad, no good, plain lousy week with a $0 co-pay copycat stalking one of its blockbusters - Endpoints News

Roche is ending the week with another dispiriting setback to reflect on. Right on the heels of its big TIGIT Phase III fail, which rattled the company from top to bottom as its share price was hammered, Sandoz announced it’s rolling out the first knockoff of …

Roche is ending the week with another dispiriting setback to reflect on. Right on the heels of its big TIGIT Phase III fail, which rattled the company from top to bottom as its share price was hamme… [+559 chars]

full article...